Andres Isaias has served as the CEO of Restem Group, Inc., in Miami since 2018. At the company focused on cell therapeutics, his responsibilities involve oversight of all Restem operations, including the management of organizational performance and alignment with short- and long-term strategic goals. Mr. Isaias also functions as the company’s ambassador, with a mission of strengthening the Restem brand, bringing cell therapeutic products to patients in need of disease treatments and communicating a unified culture that allows for continued business success.
Mr. Isaias strives to promote innovation and financial stewardship at Restem. He communicates with various stakeholders, including the Restem Board, investors, and audiences at industry conferences such as the BIO International Convention and the Jones Trading Technology and Healthcare Conference. Under his guidance, the organization continues to pursue potentially best-in-class and safe cell therapeutic products and services, with the goal of providing patients in need of disease treatments.
Andres Isaias studied engineering and business as an undergraduate at Tulane University in New Orleans. In addition to his leadership activities at Restem, he has experience in the real estate, energy and natural gas industries.